TEACHERS ADVISORS, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,605,000
+8.5%
102,889
+2.8%
0.00%
-20.0%
Q4 2018$3,324,000
-66.3%
100,058
-48.9%
0.01%
-16.7%
Q3 2018$9,862,000
+72.4%
195,882
+104.9%
0.01%
-14.3%
Q2 2018$5,721,000
+42.7%
95,589
+9.2%
0.01%
+40.0%
Q1 2018$4,008,000
+14.7%
87,513
-0.2%
0.01%
+25.0%
Q4 2017$3,495,000
-23.8%
87,715
-23.5%
0.00%
-33.3%
Q3 2017$4,586,000
-77.2%
114,653
-75.4%
0.01%
-78.6%
Q2 2017$20,087,000
+47.1%
466,060
+6.9%
0.03%
+40.0%
Q1 2017$13,651,000
+26.2%
436,121
+1.8%
0.02%
+17.6%
Q4 2016$10,814,000
-28.6%
428,260
-30.1%
0.02%
-32.0%
Q3 2016$15,145,000
+23.0%
612,409
+1.3%
0.02%
+19.0%
Q2 2016$12,309,000
+46.7%
604,277
+9.8%
0.02%
+40.0%
Q1 2016$8,390,000
+23.8%
550,195
+9.1%
0.02%
+15.4%
Q4 2015$6,775,000
+7.1%
504,095
+11.8%
0.01%0.0%
Q3 2015$6,328,000
-5.4%
451,035
+14.5%
0.01%
+8.3%
Q2 2015$6,688,000
+1005.5%
393,862
+686.7%
0.01%
+1100.0%
Q1 2015$605,000
+45.4%
50,0650.0%0.00%0.0%
Q4 2014$416,000
-4.4%
50,0650.0%0.00%0.0%
Q3 2014$435,000
-20.6%
50,0650.0%0.00%0.0%
Q2 2014$548,000
+166.0%
50,065
+117.6%
0.00%
Q1 2014$206,000
+67.5%
23,012
+40.6%
0.00%
Q4 2013$123,000
+2.5%
16,3720.0%0.00%
Q3 2013$120,000
+13.2%
16,372
-0.7%
0.00%
Q2 2013$106,00016,4890.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders